Drug intelligence / Profile preview

relaxane

Development stage
Phase 4
Lead developer
Max Zeller Söhne
Modality
Small Molecules
Administration
Oral
01

Overview

Relaxane is a herbal medicinal product developed by Max Zeller Söhne (Zeller Medical AG). It is a fixed-dose combination containing extracts of butterbur (*Petasites hybridus*), valerian root (*Valeriana officinalis*), passionflower (*Passiflora incarnata*), and lemon balm (*Melissa officinalis*). It is indicated for the treatment of nervous tension, restlessness, anxiety, and associated symptoms such as gastrointestinal spasms or sleep disturbances. The mechanism of action involves the synergistic effects of its components, primarily modulating the GABAergic system to provide sedative and anxiolytic effects. Specifically, valerian and passionflower extracts are thought to act as positive allosteric modulators of GABA-A receptors, while lemon balm inhibits GABA transaminase, thereby increasing GABA levels in the brain. Butterbur extracts contribute spasmolytic properties, potentially through the inhibition of leukotriene synthesis and calcium channel modulation.

Brand names
RelaxaneZeller Entspannung
Other names
Zeller Entspannung film coated tablet
02

Targets

ABAT (4-aminobutyrate aminotransferase)GABRR (GABA-A receptor subunit rho)LTCC (Voltage-gated calcium channel (L-type))

Beyond the preview

Go deeper on relaxane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on relaxane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call